FindTrial
Sign In

M518101 phase III 52-Week long term study in plaque psoriasis and palmoplantar keratoderma patients

M518101 phase III 52-Week long term study in plaque psoriasis and palmoplantar keratoderma patients

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222895
Enrollment
Unknown
Registered
2015-06-25
Start date
2015-06-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plaque psoriasis and palmoplantar keratoderma

Interventions

investigational material(s) Generic name etc : M518101 INN of investigational material : Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational mater

Sponsors

Maruho Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with plaque psoriasis or palmoplantar keratoderma

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
safety (adverse events and laboratory test) efficacy (severity of plaque psoriasis and palmoplantar keratoderma)—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026